Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00446654
What this trial is testing

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Who this might be right for
Age Related Macular Degeneration
Progen Pharmaceuticals 43
Not applicableLooking for participantsNCT02669953
What this trial is testing

Aflibercept in Recurrent or Persistent CNV

Who this might be right for
Age Related Macular DegenerationIntravitreal InjectionsDiabetic Macular Edema
Medical University of Vienna 80
Not applicableStudy completedNCT07375901
What this trial is testing

The Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

Who this might be right for
AMD
The Filatov Institute of Eye Diseases and Tissue Therapy 30
Not applicableStudy completedNCT00464581
What this trial is testing

Lucentis for Treatment of Macular Edema

Who this might be right for
Cystoid Macular Edema
Retina Institute of Hawaii 30
Testing effectiveness (Phase 2)Ended earlyNCT03846193
What this trial is testing

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+4 more
Gyroscope Therapeutics Limited 56
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Not applicableUnknownNCT06582511
What this trial is testing

Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients

Who this might be right for
Macular Degeneration, Age Related
Francesco Bandello 30
Very early researchLooking for participantsNCT04008121
What this trial is testing

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Who this might be right for
RetinopathyRetinal Vein OcclusionDiabetic Retinopathy+1 more
MediBeacon 10
Not applicableNot Yet RecruitingNCT06198452
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
VIS, Inc. 200
Not applicableWithdrawnNCT00487838
What this trial is testing

Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants

Who this might be right for
Age-Related Macular ChangesAge-Related Macular DegenerationCataract and IOL Surgery+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableStudy completedNCT01318941
What this trial is testing

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Who this might be right for
Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular Edema+1 more
Novartis Pharmaceuticals 30,490
Not applicableUnknownNCT00533754
What this trial is testing

Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population

Who this might be right for
Age-Related Macular Degeneration
Rudolf Foundation Clinic
Not applicableUnknownNCT04268836
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Optimal Acuity Corporation 200
Early research (Phase 1)Study completedNCT00973011
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Genentech, Inc. 18
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Not applicableStudy completedNCT05427994
What this trial is testing

Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients

Who this might be right for
Age-Related Macular Degeneration
Asfendiyarov Kazakh National Medical University 458
Not applicableStudy completedNCT02550002
What this trial is testing

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 150
Not applicableUnknownNCT01348672
What this trial is testing

Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye

Who this might be right for
Age Related Macular DegenerationGlaucomaDiabetic Retinopathy.
University of Toronto 381
Testing effectiveness (Phase 2)Ended earlyNCT01471054
What this trial is testing

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Who this might be right for
Macular EdemaCystoid Macular EdemaUveal Melanoma+2 more
Arman Mashayekhi 6
Post-approval studies (Phase 4)Study completedNCT01722045
What this trial is testing

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

Who this might be right for
Age - Related Macular Degeneration (AMD)
Regeneron Pharmaceuticals 154
Next Page